Healthcare provider profile · identity verified

Nathan Ralph Cohen, M.D.

Internal Medicine · TAYLOR, TX · NPI 1306806203

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	265	82
Levothyroxine Sodium	Levothyroxine Sodium	235	72
Pantoprazole Sodium	Pantoprazole Sodium	234	71
Gabapentin	Gabapentin	214	56
Losartan Potassium	Losartan Potassium	205	69
Prednisone	Prednisone	203	118
Amlodipine Besylate	Amlodipine Besylate	185	66
Furosemide	Furosemide	162	53
Metoprolol Succinate	Metoprolol Succinate	153	51
Lisinopril	Lisinopril	133	44
Tamsulosin Hcl	Tamsulosin Hcl	129	35
Simvastatin	Simvastatin	120	36
Azithromycin	Azithromycin	113	82
Tramadol Hcl	Tramadol Hcl	110	31
Fluticasone Propionate	Fluticasone Propionate	107	37
Montelukast Sodium	Montelukast Sodium	107	35
Omeprazole	Omeprazole	107	31
Rosuvastatin Calcium	Rosuvastatin Calcium	103	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	21
Lorazepam	Lorazepam	92	20
Allopurinol	Allopurinol	91	30
Eliquis	Apixaban	88	22
Potassium Chloride	Potassium Chloride	82	26
Albuterol Sulfate Hfa	Albuterol Sulfate	79	32
Alendronate Sodium	Alendronate Sodium	72	18
Jardiance	Empagliflozin	70	19
Ozempic	Semaglutide	67	17
Sertraline Hcl	Sertraline Hcl	65	20
Metformin Hcl Er	Metformin Hcl	64	25
Spironolactone	Spironolactone	64	21
Trazodone Hcl	Trazodone Hcl	63	24
Alprazolam	Alprazolam	60	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	60	19
Zolpidem Tartrate	Zolpidem Tartrate	60	suppressed
Meloxicam	Meloxicam	59	22
Metformin Hcl	Metformin Hcl	59	23
Pregabalin	Pregabalin	58	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	56	15
Mirtazapine	Mirtazapine	52	16
Pravastatin Sodium	Pravastatin Sodium	52	21
Famotidine	Famotidine	50	16
Clonazepam	Clonazepam	49	suppressed
Donepezil Hcl	Donepezil Hcl	48	13
Duloxetine Hcl	Duloxetine Hcl	48	17
Bupropion Xl	Bupropion Hcl	47	14
Clopidogrel	Clopidogrel Bisulfate	46	16
Carvedilol	Carvedilol	44	17
Doxycycline Monohydrate	Doxycycline Monohydrate	44	35
Ezetimibe	Ezetimibe	44	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Metoprolol Tartrate	Metoprolol Tartrate	44	16
Tizanidine Hcl	Tizanidine Hcl	44	15
Triamcinolone Acetonide	Triamcinolone Acetonide	44	27
Glimepiride	Glimepiride	42	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	30
Ondansetron Odt	Ondansetron	41	17
Atenolol	Atenolol	40	11
Januvia	Sitagliptin Phosphate	40	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	13
Buspirone Hcl	Buspirone Hcl	35	15
Celecoxib	Celecoxib	34	11
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	12
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	13
Finasteride	Finasteride	29	suppressed
Myrbetriq	Mirabegron	28	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	28	11
Baclofen	Baclofen	27	suppressed
Nystatin	Nystatin	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Latanoprost	Latanoprost	25	suppressed
Mupirocin	Mupirocin	25	14
Synthroid	Levothyroxine Sodium	25	suppressed
Diazepam	Diazepam	24	suppressed
Estradiol	Estradiol	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	23
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Naproxen	Naproxen	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Fluconazole	Fluconazole	19	13
Lovastatin	Lovastatin	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Methocarbamol	Methocarbamol	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Levofloxacin	Levofloxacin	17	17
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Temazepam	Temazepam	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Cefuroxime	Cefuroxime Axetil	14	13
Cephalexin	Cephalexin	14	13
Lamotrigine	Lamotrigine	14	suppressed
Linzess	Linaclotide	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Desonide	Desonide	13	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Lactulose	Lactulose	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error